Incidental Liver Lesions

Quick Reference Images

Incidental liver mass detected on CT flowchart
Incidental CT FlowchartClick to enlarge
Polycystic liver disease management flowchart
Polycystic Liver DiseaseClick to enlarge
Hypervascular liver lesion differential diagnosis
Hypervascular DDxClick to enlarge
Liver mass enhancement pattern algorithm
Enhancement PatternsClick to enlarge

Initial Triage

First question Known malignancy, cirrhosis, chronic hepatitis, or other HCC risk changes the pathway.

No cancer / no HCC risk

  • Many incidental lesions are benign: cyst, hemangioma, FNH, focal fat, or perfusional change.
  • Subcentimeter lesion with benign features usually needs no follow-up.
  • Indeterminate lesion on ultrasound or single-phase CT: characterize with contrast MRI or multiphasic CT.

Cancer or chronic liver disease

  • Lower threshold for dedicated multiphasic CT/MRI.
  • Cirrhotic or HCC-risk patients should generally use LI-RADS rather than this page.
  • Known cancer history: evaluate for metastasis if imaging features are not diagnostic benign.

Benign Patterns

No follow-up when classic

  • Simple cyst: water attenuation/signal, no enhancement, no solid component.
  • Hemangioma: peripheral nodular discontinuous enhancement with progressive fill-in.
  • FNH: arterial hyperenhancement, central scar when present, and typical hepatobiliary phase retention.
  • Focal fat or focal fat sparing in characteristic locations with no mass effect.

Polycystic liver disease

  • No cyst-related symptoms: usually no treatment or follow-up.
  • Symptomatic dominant cyst: aspiration/sclerotherapy or fenestration may be considered.
  • Diffuse severe symptomatic disease: specialty referral for medical, surgical, or transplant options.

Indeterminate / Suspicious

Hypervascular lesion

  • Benign possibilities: hemangioma, FNH, adenoma, perfusional phenomenon.
  • Suspicious possibilities: HCC in at-risk liver, hypervascular metastasis, cholangiocarcinoma, or mixed tumor.
  • Use arterial, portal venous, delayed, and hepatobiliary phase patterns when available.

Adenoma / suspicious mass

  • Hepatic adenoma management depends on size, subtype, growth, sex, and hormone exposure.
  • Lesions around 5 cm or larger, growing, hemorrhagic, or beta-catenin subtype often need specialty management.
  • If still indeterminate after high-quality imaging, consider short interval follow-up, multidisciplinary review, or biopsy.

Sources

Secondary Links